Ref ID: 19524
Author:
JA Ferreira1,2,3*, H Nazik4, JC Penner2, KV Clemons2,3, RB Moss3, N Banaei3, DA Stevens2,3
Author address:
1School of Medicine, Faculdade da Saúde e Ecologia Humana, Vespasiano, Brazil
2California Institute for Medical Research, San Jose, USA
3Stanford University School of Medicine, Stanford University, Stanford, USA
4Department of Medical Microbiology
Full conference title:
6th Advances Against Aspergillosis 2014
Abstract:
Purpose:
Co-colonization by Pa and Af in airways of cystic fibrosis (CF) patients is associated with worse
clinical outcomes. Our objective was to study in vitro the action of Pa on Af metabolism and the
ability of Af to establish a biofilm (AfBF).
Methods:
One Af strain (10AF), and 26 clinical Pa isolates (16 non-CF isolates (nonCF), 5 CF mucoid variant
(CFMuc), 5 CF non-mucoid (CFNMuc)) were studied. Biofilms were developed on polystyrene disks
in RPMI +10% fetal bovine serum in 12-well plates. Starting with 3×105 conidia, AfBF occurred
in 16 h. 3×107 live Pa cellsorspent culture filtrate (SCF) from Pa grown under planktonic (PK) or
biofilm (BF) conditions, or fresh medium (controls), were added to conidia initially, and after 16 h
fresh medium was substituted for 24 h further incubation. Af metabolic activity was quantified by
the XTT assay. Statistical differences were evaluated using one-way analysis of variance (ANOVA)
followed by a Tukey post-hoc test; statistical significance was considered p 8804;0.05.
Results:
All Pa isolates inhibited the metabolism of Af and AfBF development (p<0.001). CFMuc and
CFNMuc isolates were more inhibitory than nonCF (p<0.001), and CFNMuc isolates were more
inhibitory than CFMuc isolates (p<0.01). SCF from Pa cultures alone, from all 3 Pa types, grown
under either PK or BF conditions, were inhibitory to the Af (p<0.001, all 6 comparisons). SCF from
PK nonCF was less inhibitory (p<0.001) than that from either CFNMuc or CFMuc isolates; the 2 CF
types were not significantly different. SCF from nonCF Pa grown as BF was not different than that
from CFMuc isolates, but SCF from CFNMuc isolates was significantly more inhibitory than those
from nonCF or CFMuc (p<0.001). Furthermore, SCF from all 3 types of Pa grown as BF appeared
more inhibitory than SCF from Pa grown in PK conditions. Serial dilution experiments of intact
media with distilled water indicated the inhibition noted with SCF was not due merely to the effect
of prior exhaustion of SCF, but due to inhibitory substances for Af produced by Pa.
Conclusions:
Pa isolates were inhibitory to Af, though isolates from CF patients are more inhibitory, and nonmucoid
CF isolates are most inhibitory. The inhibition, and the differences between Pa isolates,
appear the result of soluble inhibitory substances, produced to a greater level when Pa was grown
under biofilm conditions. Thus, direct microbial contact was not required. Since the development
of mucoid Pa is a late development in CF airways, an hypothesis is that this development is less
inhibitory to Af, allowing the formation of Af biofilm in the airways, explaining why Af establishment
in airways usually occurs later in CF disease following conversion of environmental non-mucoid to
non-mucoid Pa phenotypes in situ, to mucoid types.
Abstract Number: 51
Conference Year: 2014
Link to conference website: http://www.AAA2014.org
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a